4D Molecular Therapeutics, Inc. (FDMT) Reports Q2 Loss, Lags Revenue EstimatesZacks Investment Research • 08/08/24
4DMT Advances Leadership in Large Market Ophthalmology with Senior Management Hires and Formation of Ophthalmology Advisory BoardGlobeNewsWire • 08/05/24
FDMT INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into 4D Molecular Therapeutics, Inc. and Encourages Clients to Contact the Firm!Accesswire • 08/02/24
FDMT SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into 4D Molecular Therapeutics, Inc. and Encourages Shareholders to Contact the Firm Today!Accesswire • 08/01/24
4D Molecular Therapeutics, Inc. (FDMT) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged WrongdoingsGlobeNewsWire • 07/31/24
FDMT INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into 4D Molecular Therapeutics, Inc. and Encourages Shareholders to Contact the Firm Today!Accesswire • 07/31/24
4D Molecular Therapeutics, Inc. (FDMT) Shareholders May Have Been Affected by Fraud- Levi & Korsinsky InvestigatesAccesswire • 07/30/24
Levi & Korsinsky Reminds Shareholders of an Investigation into 4D Molecular Therapeutics, Inc. (FDMT) Regarding Potential Securities Fraud AllegationsAccesswire • 07/30/24
FDMT STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into 4D Molecular Therapeutics, Inc. and Encourages Investors to Contact the Firm Today!Accesswire • 07/30/24
Lost Money on 4D Molecular Therapeutics, Inc. (FDMT)? Contact Levi & Korsinsky Regarding an Ongoing InvestigationAccesswire • 07/30/24
The Schall Law Firm Invites FDMT Investors To Join The Securities Fraud Investigation Of 4D Molecular Therapeutics IncAccesswire • 07/30/24
4D Molecular Therapeutics, Inc. INVESTIGATION: Levi & Korsinsky Investigates Potential Securities Fraud by 4D Molecular Therapeutics (FDMT)Accesswire • 07/29/24
The Schall Law Firm Invites FDMT Investors To Participate In The Securities Fraud Investigation Of 4D Molecular Therapeutics Inc.Accesswire • 07/29/24
4D Molecular Therapeutics, Inc. (FDMT) Investors with Losses are Urged to Contact Levi & Korsinsky to Discuss Their RightsAccesswire • 07/29/24
FDMT SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into 4D Molecular Therapeutics, Inc. and Encourages Investors to Contact the Firm Today!Accesswire • 07/29/24
FDMT INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into 4D Molecular Therapeutics, Inc. and Encourages Investors to Contact the Firm Today!Accesswire • 07/28/24
Investors who lost money on 4D Molecular Therapeutics, Inc. should contact Levi & Korsinsky about an ongoing investigation - FDMTAccesswire • 07/26/24
FDMT SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into 4D Molecular Therapeutics, Inc. and Encourages Stockholders to Contact the Firm!Accesswire • 07/26/24
An Investigation Has Commenced on Behalf of 4D Molecular Therapeutics, Inc. Shareholders. Contact Levi & Korsinsky to Discuss your FDMT Losses.Accesswire • 07/25/24
The Schall Law Firm Invites FDMT Investors To Join The Securities Fraud Investigation Of 4D Molecular Therapeutics Inc.Accesswire • 07/25/24
FDMT ALERT- Levi & Korsinsky Has Commenced an Investigation on Behalf of 4D Molecular Therapeutics, Inc. Shareholders Who Lost MoneyAccesswire • 07/25/24
FDMT INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into 4D Molecular Therapeutics, Inc. and Encourages Stockholders to Contact the Firm!Accesswire • 07/25/24
Lost Money on 4D Molecular Therapeutics, Inc.(FDMT)? You May Have Been Affected by Fraud- Contact Levi & KorsinskyAccesswire • 07/24/24
FDMT ACTIVE INVESTIGATION: Contact Levi & Korsinsky if you lost money on your 4D Molecular Therapeutics, Inc. investmentAccesswire • 07/24/24
FDMT STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into 4D Molecular Therapeutics, Inc. and Encourages Shareholders to Contact the Firm!Accesswire • 07/24/24
